Inventor · disambiguated record
Marcel Viellevoye
Also filed as: VIELLEVOYE MARCEL
19 granted patents·7 pending applications·52 citations·filing 2001–2023
92Inventor score
Top patents by PatentIndex Score
26 records- 0191US10653711B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 19, 2020·6 cites·18 claims
- 0287US7816360B2MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocyclesJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Oct 19, 2010·9 cites·23 claims
- 0385US7504400B2MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocyclesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Mar 17, 2009·8 cites·13 claims
- 0484US6878724B2Polyarylcarboxamides useful as lipid lowering agentsJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Apr 12, 2005·14 cites·6 claims
- 0583US11318157B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·4 claims
- 0683US8114880B2Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid MTP inhibiting compoundsMEERPOEL LIEVEN·Filed 2007·Granted Feb 14, 2012·9 cites·10 claims
- 0779US7253157B2Polyarylcarboxamides useful as lipid lowering agentsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 7, 2007·2 cites·6 claims
- 0879US7169796B2Polyarylcarboxamides useful as lipid lowering agentsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jan 30, 2007·2 cites·5 claims
- 0977US2024124493A1Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1077US2023330127A16-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1174US11883367B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 1274US11597746B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2019·Granted Mar 7, 2023·1 cites·53 claims
- 1373US2023287034A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1468US11993614B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 28, 2024·0 cites·16 claims
- 1567US2023146410A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1664US2008125412A1Polyarylcarboxamides useful as lipid lowering agentsMEERPOEL LIEVEN·Filed 2007·Application pending·0 cites
- 1763US7528154B2Polyarylcarboxamides useful as lipid lowering agentsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 5, 2009·0 cites·5 claims
- 1860US11098062B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 24, 2021·0 cites·6 claims
- 1959US11492367B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 2058US8354402B2Polyarylcarboxamides useful as lipid lowering agentsJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 15, 2013·0 cites·6 claims
- 2150US2021009630A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 2246US8772494B2N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein bMEERPOEL LIEVEN·Filed 2004·Granted Jul 8, 2014·0 cites·8 claims
- 2344US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
- 2441US7642378B2Lipid lowering biphenylcarboxamidesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Jan 5, 2010·0 cites·7 claims
- 2533US10017509B2Macrocylic pyrimidine derivativesJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jul 10, 2018·0 cites·12 claims
- 2633US2017022201A1Macrocylic pyridine derivativesJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marcel Viellevoye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →